Related Experiment Video
Updated: Jul 14, 2026

Dithranol as a Matrix for Matrix Assisted Laser Desorption/Ionization Imaging on a Fourier Transform Ion Cyclotron Resonance Mass Spectrometer
Published on: November 26, 2013
Bruker Daltonics: leading the way from basic research to mass-spectrometry-based clinical applications
1Bruker Daltonik GmbH, Fahrenheitstrasse 4, 28359 Bremen, Germany. Wolfgang.Pusch@bdal.de
Abstract:
For several years, Bruker Daltonics has been committed to the development of new applications of mass spectrometry in clinical research, which have the potential to become next-generation diagnostic procedures. After introducing the CLINPROTtrade mark product a couple of years ago, for biofluid analysis in the search of predictive peptide biomarkers indicating certain disease conditions, Bruker Daltonics recently expanded their portfolio with the MALDI BioTypertrade mark and the MALDI Molecular Imagertrade mark to enter new markets, such as the identification of microorganisms and molecular imaging. This article focuses on the current activities and future perspectives of these new clinical research solutions.
Related Concept Videos
MALDI-TOF Mass Spectrometry
Tandem Mass Spectrometry
Mass Spectrometers
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
Rapid Identification of Pathogens

